Novavax Inc

NVAX

NASDAQ. Currency in USD

18.20 -0.37 ( -1.99% )

Real time prices: September 30

Market Cap.
1.42B
Beta (5Y monthly)
1.64
Price/Earnings
-
EPS (TTM)
-19.46
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
3.76M
1y Target Est.
268.00
Day's Range
18.16
-
19.60
52 Week's Range
17.85
-
236.50

Historical Summary

Performance
EPS growth
Share Buybacks

About Novavax Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.novavax.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
75.61M
Employees
1541
Address
21 Firstfield Road, Gaithersburg, MD, United States, 20878
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Latest news

Novavax (NVAX) Dips More Than Broader Markets: What You Should Know
Novavax (NVAX) Dips More Than Broader Markets: What You Should Know

Novavax (NVAX) closed the most recent trading day at $18.20, moving -1.99% from the previous...
By Zacks Investment Research - 2 days ago

Novavax: Beware This Hypercoaster
Novavax: Beware This Hypercoaster

Novavax is the hypercoaster of stocks having crested $300 in 02/22, falling to <$130 and...
By Seeking Alpha - 3 days ago

These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?
These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?

These vaccine makers have lost much of the momentum they built earlier in the pandemic.
By The Motley Fool - 3 days ago

Canada to scrap mask mandate on planes, joining Japan, Hong Kong and U.A.E. in lifting COVID restrictions
Canada to scrap mask mandate on planes, joining Japan, Hong Kong and U.A.E. in lifting COVID restrictions

The Canadian government announced Monday it will no longer require people to wear masks on...
By MarketWatch - 4 days ago

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics...
By Benzinga - 4 days ago

Ryder System, Harrow Health And Other Big Gainers From Tuesday
Ryder System, Harrow Health And Other Big Gainers From Tuesday

U.S. stocks closed mixed with the Dow Jones dropping around 125 points on Tuesday. Here...
By Benzinga - 5 days ago

Why Novavax Is Bouncing Back Today
Why Novavax Is Bouncing Back Today

1 million doses of the company's COVID-19 vaccine are now available in the U.K.
By The Motley Fool - 5 days ago

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares surged 159.9% to $9.15. Avenue Therapeutics recently received...
By Benzinga - 5 days ago